# GlaxoSmithKline Biologicals – FDA Inspection, Nov 13, 2018

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals/b7cb345e-7492-4016-bfb2-29932766b0e4
Source feed: FDA_Inspections

> FDA inspection 1074672 of GlaxoSmithKline Biologicals, November 13, 2018. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1074672
- Company Name: GlaxoSmithKline Biologicals
- Inspection Date: 2018-11-13
- Product Type: Biologics
- Center: Biologics
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- FDA Inspection 1242355 - 2024-06-04
- [FDA Inspection 1232702 - 2024-03-12](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals/70a6a284-2119-4f02-9b73-85f02c66c432)
- [FDA Inspection 1179634 - 2022-09-13](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals/b7981ae6-29ac-4d33-bb97-b46c00e4538f)

## Related Officers

- Issuing Officer
- [Company Rep](https://www.keypedia.com/people/randa-melhem/7c1d0c80-f768-487b-83a1-7145b0d0a7f8)

Company: https://www.keypedia.com/companies/glaxosmithkline-biologicals/98ade6fb-8ae1-48af-a7cf-71b26cd2e808

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8